Navigation Links
Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
Date:10/2/2007

ROCKVILLE, Md., Oct. 2 /PRNewswire/-- Meretek Diagnostics, Inc. and Otsuka America Pharmaceutical, Inc. (OAPI) today announced the completion of a merger between the two companies. The merger forms a new division of OAPI called Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc.

OAPI was established in 1989 by Otsuka America, Inc. (OAI), which is wholly owned by Otsuka Pharmaceutical Co., Ltd. (OPC). Meretek Diagnostics was acquired by OAI in 2001. Both are part of the Otsuka Pharmaceutical Group of companies. With this merger, Meretek staff members will become employees of OAPI.

Hiromi Yoshikawa, Chairman and CEO of Otsuka America Pharmaceutical, Inc., said the agreement represents a tremendous opportunity.

"We are pleased to welcome the Meretek Diagnostics organization into the OAPI organization," said Yoshikawa. "This merger presents expanded opportunities for research and development as well as for commercialization of new, innovative healthcare products."

No significant change in staffing at either organization is expected as a result of the merger.

About Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc.

Meretek Diagnostics Group is a wholly owned group of Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative, fast-growing healthcare company that commercializes Otsuka-discovered and other product opportunities in North America, with a strong focus on and commitment to neuroscience, cardiovascular and gastrointestinal therapeutic treatments. OAPI is dedicated to improving patients' health and the quality of human life. The company is part of the Otsuka Pharmaceutical Group, which is comprised of 99 companies and approximately 31,000 people around the world. With 54 consolidated subsidiaries, Otsuka earned US $7.2 billion in consolidated annual revenues in fiscal 2006. For additional information, please visit http://www.otsuka.com.

For more information about the Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc. and its products, including Full Prescribing Information, Warnings and Limitations, visit the Meretek Website at http://www.meretek.com or the OAPI Website at http://www.otsuka.com.


'/>"/>
SOURCE Meretek Diagnostics Group of Otsuka AmericaPharmaceutical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
2. Lab Tests And Diagnostics - Next Wave Of Outsourcing
3. Innovation Needed In The Field Of Diagnostics: Nair
4. Abstain from sex- the latest mantra of American teens
5. Clintons new problem - Is the outgoing American president suffering from skin cancer?
6. American scientists alter gene makeup of babies
7. FDA attacks American Red Cross for blood violations
8. Poll Finds Many Americans Misinformed About Cancer
9. Poll Finds Many Americans Misinformed About Cancer
10. Hypertension Drug of Choice for African Americans
11. Indian doctors in America help Katrina victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care ... for the treatment program located in Royal Oak, Michigan. IDC, formerly known ... are focused on providing the highest standards in the field of eating disorder treatment ...
(Date:7/26/2017)... ... July 26, 2017 , ... BioPlus Specialty ... an updated version of the HCV Treatment Path app (version 4.4.0) to keep ... virus (HCV) infection. All of the latest HCV medications are included in this ...
(Date:7/25/2017)... Beach, Florida (PRWEB) , ... July 25, 2017 ... ... employee, Jennifer Haller, to the sales department joining as Regional Account Manager for ... relationships with contracted customers in the liquidation of their obsolete medical assets. , ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Donna Bergman, ... recently co-authored and published an article in the medical science journal Physical Medicine ... Both the article and the research that helped produce it, were written and ...
(Date:7/25/2017)... ... 25, 2017 , ... USHEALTH Group, Inc. has been announced ... World Awards®. The coveted annual CEO World Awards program encompasses the world’s best ... social responsibility, and milestones from every major industry in the world. Organizations from ...
Breaking Medicine News(10 mins):
(Date:7/25/2017)... and CAMBRIDGE, Massachusetts , July 25, 2017 ... repurposing drugs to treat rare nervous system diseases, has concluded ... develop and market the drug SOM0226 against transthyretin amyloidosis (ATTR). ... very promising results in a Phase 2 study conducted in ... office in the United States ...
(Date:7/24/2017)... , July 24, 2017 IBM (NYSE: IBM ... Magic Quadrant for Solid-State Arrays (SSA) for the fourth year ... According to Gartner, "Vendors in the Leaders quadrant have ... of Vision. A vendor in the Leaders quadrant has the ... drive the acceptance of new technologies. These vendors demonstrate a ...
(Date:7/21/2017)... N.Y. and EDMONTON, Alberta ... IBM ) scientists and the University of Alberta ... published new data in Nature,s partner journal, Schizophrenia ... algorithms helped predict instances of schizophrenia with 74% ... predicted the severity of specific symptoms in schizophrenia ...
Breaking Medicine Technology: